4th Quarter - Report

NATIONAL KIDNEY FOUNDATION for NATIONAL KIDNEY FOUNDATION

Firm
Client
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2026 Appropriations for organ donation and transplantation activities (HRSA). FY 2026 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2026 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2026 Appropriations for Dept. of Defense Congressionally Directed Medical Research Program. FY 2026 Appropriations for Indian Health Service.

LobbyistCovered position, as disclosed
LAUREN DREW —
TROY ZIMMERMAN —

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Indian Health Service; Centers For Disease Control & Prevention (CDC); SENATE

Health Issues HCR

Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.

LobbyistCovered position, as disclosed
LAUREN DREW —
MIRIAM ELIZABETH GODWIN —
TROY ZIMMERMAN —

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Commerce, Dept of (DOC); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 4583 (119th), H.R. 4582 (119th), S. 1552 (119th), S. 957 (119th), H.R. 1518 (119th), H.R. 628 (119th)

Medicare/Medicaid MMM

Initiatives to expand access to home dialysis. Request to Reinstate Race & Ethnicity Data Collection in the ESRD Quality Reporting System. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.

LobbyistCovered position, as disclosed
LAUREN DREW —
MIRIAM ELIZABETH GODWIN —
TROY ZIMMERMAN —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 4231 (119th), S. 1973 (119th), S. 1261 (119th), H.R. 4206 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.